← Back to Search

THRIVE Intervention for Transition Care

N/A
Waitlist Available
Led By Margo B Brooks Carthon, PhD RN
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 18 months
Awards & highlights

Study Summary

This trial aims to compare outcomes for Medicaid patients who receive post-discharge support vs. usual care. Home care nurses, care coordination teams and physicians will oversee care for 30 days.

Who is the study for?
This trial is for adults with Medicaid insurance in Pennsylvania who have been hospitalized and agree to home care. It's not for anyone under 18. The study looks at how well they do after leaving the hospital when they get extra support.Check my eligibility
What is being tested?
The THRIVE intervention is being tested, which includes a referral to home care services within 48 hours of discharge, oversight by a physician or provider for 30 days, and weekly case conferences to address health and social needs.See study design
What are the potential side effects?
Since THRIVE is a service-based intervention rather than a medication, it doesn't have traditional side effects. However, there may be issues related to the acceptability and effectiveness of the provided services.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Care or Specialist Visit
Rates of Emergency Department Visit
Rates of Readmissions
+1 more
Secondary outcome measures
Feasibility, Acceptability, Appropriateness, Workload

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: THRIVE InterventionExperimental Treatment1 Intervention
1 month intensive post discharge case management and care coordination.
Group II: Usual CareActive Control1 Intervention
Discharge to home without intensive post acute case management or care coordination.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,879,821 Total Patients Enrolled
3 Trials studying Transition Care
13,206 Patients Enrolled for Transition Care
Rita & Alex Hillman FoundationUNKNOWN
2 Previous Clinical Trials
73 Total Patients Enrolled
Margo B Brooks Carthon, PhD RNPrincipal InvestigatorUniversity of Pennsylvania

Media Library

THRIVE Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05714605 — N/A
Transition Care Research Study Groups: THRIVE Intervention, Usual Care
Transition Care Clinical Trial 2023: THRIVE Intervention Highlights & Side Effects. Trial Name: NCT05714605 — N/A
THRIVE Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05714605 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this study permit those who are younger than fifty-five years old to participate?

"The terms of eligibility for this clinical trial dictate that applicants must be between 18 and 99 years old."

Answered by AI

Who meets the eligibility criteria to participate in this clinical experiment?

"In order to enroll in this medical trial, patients should have previously received transition care and be aged between 18-99 years. This research is hoping to enlist a total of 267 individuals."

Answered by AI

Are any individuals currently being admitted to this research?

"The information on clinicaltrials.gov states that recruitment for the trial in question has ceased - which first went live on March 27th 2023 and was last edited April 5th, 2023. For those wishing to be involved with a similar study, there are 4 active trials currently recruiting participants."

Answered by AI
~0 spots leftby May 2024